Title : Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.

Pub. Date : 2017 Mar 23

PMID : 28049642






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In the subgroup analyses, clofarabine improved overall survival and EFS for European Leukemia Net (ELN) 2010 intermediate I prognostic risk AML (EFS, 26% +- 4 vs 40% +- 5 at 4 years; Cox P = .002) and for the intermediate risk genotype NPM1 wild-type/FLT3 without internal-tandem duplications (EFS, 18% +- 5 vs 40% +- 7; Cox P < .001). Clofarabine nucleophosmin 1 Homo sapiens